A. Borovika, P. Nagorny / Tetrahedron 69 (2013) 5719e5725
5723
Burfield et al.19 All reactions were carried out under an atmosphere
of nitrogen in flame- or oven-dried glassware with magnetic stir-
ring. Reactions were cooled via external cooling baths: ice water
(0 ꢁC), Neslab Cryotrol CB-80 immersion cooler (0 to ꢀ60 ꢁC) or
Neslab Cryocool immersion cooler CC-100 II. Purification of the re-
actions mixtures was performed by flash chromatography using
SiliCycleSiliaFlash P60 (230e400 mesh) silica gel. The enantiomeric
ratios (e.r.) were determined on Alliance Waters (separations
module e2695, detector 2998) using CHIRALCEL OD-H column
phosphoryl chloride prepared above in dry THF (0.9 mL) again
at ꢀ78 ꢁC. The resulting reaction mixture was refluxed for 16 h.
After that the reaction mixture was brought to room temperature
and quenched with water. Organic products were extracted with
DCM. Extract was then washed with 4 N HCl and dried over an-
hydrous magnesium sulfate. The desired product was purified via
preparatory TLC (10:1 DCM/Et2O) and washed again with 4 N HCl to
provide a white solid, 42.2 mg, 49% yield; IR (thin film, cmꢀ1) 2961,
2922, 2869, 1595, 1432, 1364, 1203, 1151, 910, 733. 1H NMR
(4.6 mmꢂ250 mm, 5
m
m) by comparing the samples with the ap-
(700 MHz, CDCl3)
d
8.15 (s, 1H), 8.06 (s, 1H), 8.02 (d, J¼8.3 Hz, 1H),
propriate racemic mixtures. 1H NMR spectra were recorded on
Varian vnmrs 700 (700 MHz), Varian vnmrs 500 (500 MHz), Varian
MR400 (400 MHz), Varian Inova 500 (500 MHz) spectrometers and
7.99 (d, J¼8.3 Hz, 1H), 7.58e7.51 (m, 5H), 7.51e7.42 (m, 4H),
7.38e7.30 (m, 3H), 1.37 (s, 18H), 1.34 (s, 18H); 13C NMR (175 MHz,
CDCl3) 151.5, 150.9, 144.0, 143.5, 135.7, 135.2, 134.9, 134.3, 132.3,
132.03, 131.99, 131.96, 128.8, 128.6, 127.4, 127.3, 127.0, 126.6, 124.6,
124.4, 122.9, 122.8, 122.5, 122.2, 35.21, 35.18, 31.6; 31P NMR
chemical shifts (
solvent resonance as the internal standard (CDCl3 at
d
) are reported in parts per million (ppm) with
7.26). Data are
d
reported as (br¼broad, s¼singlet, d¼doublet, t¼triplet, q¼quartet,
qn¼quintet, sext¼sextet, m¼multiplet; coupling constant(s) in
Hertz; integration). Proton-decoupled 13C NMR, as well as 19F and
31P spectra were recorded on Varian vnmrs 500 (500 MHz) or Varian
(283 MHz, CDCl3)
d
ꢀ11.0 (s); 19F NMR (376 MHz, CDCl3)
d
ꢀ77.4;
HRMS (ESIꢀ) (m/z): [MꢀH] calcd for C49H52F3NO5PS 854.3259;
found 854.3259.
vnmrs 700 (700 MHz) spectrometers and chemical shifts (
reported in ppm with solvent resonance as the internal standard
(CDCl3 at 77.2). High resolution mass spectra (HRMS) were
d
) are
5.2.2. N-((2s,11bS)-4-Oxido-2,6-bis(2,4,6-triisopropylphenyl)dinaph-
tho[2,1-d:10,20-f][1,3,2]dioxaphosphepin-4-yl) methanesulfonamide
(23). Following the procedure described by Yamamoto and Naka-
shima,4b the preparation of 23 was conducted on 0.28 mmol scale
from the corresponding BINOL derivative and sulfonamide. The
resultant product, was isolated as a white solid, 60 mg, 26% yield; IR
(thin film, cmꢀ1) 2961, 2870, 1381, 1315, 1171, 912. 1H NMR
d
recorded on MicromassAutoSpecUltima or VG (Micromass) 70-250-
S Magnetic sector mass spectrometers in the University of Michigan
mass spectrometry laboratory. Infrared (IR) spectra were recorded
as thin films on NaCl plates on a Perkin Elmer Spectrum BX FT-IR
spectrometer. Absorption peaks were reported in wavenumbers
(cmꢀ1). All previously reported phosphoramides were prepared
according to published procedures.4b,20 All commercially unavail-
able acetals and ketals were prepared following the procedure re-
ported by Lu and co-workers.21 Racemic DielseAlder reactions were
performed according to the Chavan procedure.22 Products were
then purified by flash chromatography or preparatory HPLC (Waters
(700 MHz, CDCl3) d 8.00e7.94 (m, 4H), 7.58e7.53 (m, 2H), 7.39e7.33
(m, 3H), 7.29e7.26 (m, 1H), 7.15 (dd, J¼3.1, 1.9 Hz, 2H), 7.13
(d, J¼1.7 Hz, 1H), 7.02 (d, J¼1.7 Hz, 1H), 2.98e2.95 (m, 3H),
2.73e2.68 (m, 1H), 2.60e2.52 (m, 2H), 2.42 (s, 3H), 1.43 (s, 1H), 1.30
(d, J¼7.2 Hz, 6H), 1.26 (d, J¼6.9 Hz, 9H), 1.24 (dd, J¼10.0, 6.9 Hz, 6H),
1.21 (dd, J¼6.9, 1.9 Hz, 6H), 1.09 (d, J¼6.9 Hz, 3H), 1.00 (d, J¼6.9 Hz,
3H), 0.96 (d, J¼6.9 Hz, 3H); 13C NMR (175 MHz, CDCl3)
d 149.9,
Delta 600, column Agilent Zorbax RX-SIL, 21.2ꢂ250 mm, 7
m
m) to
149.2, 148.7, 148.3, 147.2, 146.2, 146.0, 144.6, 133.0, 132.9, 132.6,
132.4, 132.3, 131.8, 131.3, 130.9, 130.7, 130.2, 128.6, 128.5, 127.5,
126.9, 126.5, 126.4, 122.1, 121.7, 121.6, 121.3, 120.3, 42.1, 34.6, 31.6,
31.4, 31.2, 30.8, 30.5, 29.9, 27.1, 27.0, 25.6, 25.2, 24.4, 24.2, 23.3, 23.2,
ensure high purity standards for developing chiral HPLC assays.
5.2. Synthesis of catalysts 17e26
23.1; 31P NMR (202 MHz, CDCl3)
d
ꢀ4.5 (s); HRMS (ESIþ) (m/z):
Catalysts 17,23 18,4b 20,20a 21,20b 22,20b 25,20c and 2620d
have been synthesized according to the previously published
procedures.
[MꢀH] calcd for C51H59NO5PS 828.3857; found 828.3854.
5.2.3. 2,3,4,5,6-Pentafluoro-N-(4-oxido-2,6-bis (2,4,6-triisopropyl-
phenyl)dinaphtho[2,1-d:10,20-f][1,3,2] dioxaphosphepin-4-yl)benze-
nesulfonamide (24). Following the procedure described by Yama-
moto and Nakshima,4b the preparation of 24 was conducted on
0.117 mmol scale from the corresponding BINOL derivative and
sulfonamide. The resultant product, 11.6 mg was isolated as a white
solid in 10% yield; IR (thin film, cmꢀ1) 2961, 2928, 2870, 1520, 1504,
1409, 1316, 1302, 1182, 1103, 996, 903, 733. 1H NMR (700 MHz,
5.2.1. N-((11bS)-2,6-Bis(3,5-di-tert-butylphenyl)-4-oxidodinaphtho
[2,1-d:10,20-f] [1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethane-
sulfonamide (19). 75.2 mg (0.104 mmol) of the corresponding chi-
ral phosphoric acid was dissolved in 0.91 mL of dry 1,2 di-
chloroethane under nitrogen atmosphere. Then 1.0
mL (0.0135 mmol)
of DMF and 44.5 L (0.519 mmol) of oxalyl chloride were added. The
m
resulting mixture was stirred at reflux for 20 h. After reaction com-
pletion volatiles were evaporated, the product was dried under high
vacuum, and subjected to the next step without further purification.
This product was isolated as a yellow solid, 77.1 mg, quantitative
yield; IR (thin film, cmꢀ1) 2962, 2868, 15.95, 1477, 1406, 1363, 1317,
CDCl3) d 8.02e7.91 (m, 4H), 7.60e7.51 (m, 2H), 7.42e7.29 (m, 4H),
7.22 (d, J¼8.9 Hz, 2H), 7.12 (d, J¼1.4 Hz, 1H), 7.06 (d, J¼1.4 Hz),
3.05e2.92 (m, 2H), 2.82e2.73 (m, 1H), 2.68e2.50 (m, 3H), 1.32
(d, J¼6.8 Hz, 12H), 1.26 (d, J¼6.8 Hz, 6H), 1.23e1.15 (m, 9H), 1.04
(d, J¼6.8 Hz, 3H), 0.98 (d, J¼6.8 Hz, 3H), 0.94 (d, J¼6.8 Hz); 13C NMR
1239, 1086, 922, 751. 1H NMR (400 MHz, CDCl3)
d
8.11 (d, J¼9.4 Hz,
(175 MHz, CDCl3) d 150.4, 148.9, 148.5, 147.7, 146.9, 146.3, 133.6,
2H), 8.02 (dd, J¼8.3, 4.8 Hz, 2H), 7.64 (d, J¼1.5 Hz, 2H), 7.58e7.51 (m,
2H), 7.47 (s, 4H), 7.44 (d, J¼8.6 Hz, 1H), 7.38e7.31 (m, 3H), 1.38 (s,
18H), 1.37 (s, 18H); 13C NMR (175 MHz, CDCl3) 151.0, 150.8, 144.52,
144.46,144.4,135.7,135.5,134.9,132.1, 132.0,131.7, 128.8,128.7,127.4,
127.3, 126.94, 126.89, 126.64, 126.62, 124.7, 123.0, 122.7, 121.9, 35.3,
133.2,132.9,132.4,132.2,131.8,131.3,130.3,130.1,129.8,128.6,127.7,
127.6, 126.9, 126.6, 126.5, 122.1, 122.0, 121.5, 121.4, 120.6, 34.6, 34.4,
31.8, 31.3, 31.2, 30.5, 29.9, 27.5, 26.9, 25.6, 25.4, 24.1, 24.0, 23.2, 23.1,
23.0, 22.7; 31P NMR (202 MHz, CDCl3)
d
ꢀ6.0 (s); 19F NMR (376 MHz,
CDCl3)
d
ꢀ135.3 (d, J¼21.9 Hz, 2F), ꢀ144.9 (ꢀ145.2) (m, 1F), ꢀ159.6
35.2, 31.7; 31P NMR (202 MHz, CDCl3)
[MþNa] calcd for C48H52ClO3PNa 765.3235; found 765.3216.
A solution of 16.3 mg (0.110 mmol) of trifluoromethanesulfony-
lamide in 0.5 mL of dry THF was treated with freshly prepared
d
8.4 (s); HRMS (ESIþ) (m/z):
(t, J¼19.1 Hz, 2F); HRMS (ESIꢀ) (m/z): [MꢀH] calcd for
C56H56F5NO5PS 980.3542; found 980.3541.
5.3. Preparation of acetals 27 in Table 4
solution of LDA made from 30.7 mL (0.219 mmol) diisopropylamine,
0.14 mL 1.6 M (0.219 mmol) n-butyllithium and dry THF (0.5 mL)
The unsaturated acetals 13,21 27a,24a 27b,24a 27c,24b 27d,24c and
27g,24d have been synthesized according to previously published
at ꢀ78 ꢁC. The resulting solution was cannulated over a solution of